3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other solid neoplasm
1
Conditions
Glioblastoma
77
Prostatic Neoplasms
56
Carcinoma, Non-Small-Cell Lung
50
Breast Neoplasms
49
Esophageal Neoplasms
47
Rectal Neoplasms
41
Lung Neoplasms
40
Squamous Cell Carcinoma of Head and Neck
32
Gliosarcoma
31
Head and Neck Neoplasms
30
Brain Neoplasms
30
Pancreatic Neoplasms
29
Uterine Cervical Neoplasms
27
Neoplasm Metastasis
23
Glioma
23
Neoplasms
22
Oropharyngeal Neoplasms
20
Esophageal Squamous Cell Carcinoma
20
Sarcoma
19
Melanoma
18
Astrocytoma
17
Adenocarcinoma Of Esophagus
15
Stomach Neoplasms
14
Precursor Cell Lymphoblastic Leukemia-Lymphoma
12
Carcinoma, Squamous Cell
12
Urinary Bladder Neoplasms
11
Lymphoma, Follicular
11
Central Nervous System Neoplasms
11
Carcinoma
11
Burkitt Lymphoma
10
Interventions
pembrolizumab
7
Radiotherapy
3
Proton Therapy
3
Interleukin-2
3
Cyclophosphamide
3
spartalizumab
2
fludarabine
2
Rosuvastatin Calcium
2
Paclitaxel
2
Ipilimumab
2
Immune Checkpoint Inhibitors
2
Cetuximab
2
Carboplatin
2
Blood Specimen Collection
2
toripalimab
1
tislelizumab
1
sotorasib
1
peposertib
1
pazopanib
1
patritumab deruxtecan
1
palbociclib
1
osimertinib
1
niraparib
1
neotil
1
necitumumab
1
mirdametinib
1
leronlimab
1
lenvatinib
1
atezolizumab
1
apatinib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Solid Tumor, Adult
×
Radiation
×
Clear all
NCT03728179
2024-02-20
RACIN
Centre Hospitalier Universitaire Vaudois
Phase 1
Completed
40 enrolled